Products with Anti-tumor promoting activity bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN5426 | Murrangatin |
| 1. Murrangatin and murracarpin show chondroprotective activity by downregulation of interleukin-1β, tumor necrosis factorα, prostaglandins E2,and matrix metalloproteinases -13, and both of them may be a new backbone for developing inhibitors of cyclooxygenase 2. 2. Murrangatin can significantly inhibit Epstein–Barr virus early antigen (EBV–EA) activation, and preserve the high viability of Raji cells, suggests that it may be a valuable anti-tumor-promoting agent. 3. Murrangatin exhibits cytotoxicity against cholangiocarcinoma cell line, KKU-100. 4. Murrangatin exhibits antibacterial activity against P. gingivalis (ATCC 33277). 5. Murrangatin shows soluble epoxide hydrolase inhibitory activity with IC50 values 13.9±6.5uM. | |
| BCN5611 | Oleuropeic acid |
| 1. (+)-Oleuropeic acid shows potent in vitro antitumor-promoting activity, it also suppresses an in vivo two-stage carcinogenesis induced with nitric oxide and 12-O-tetradecanoyl phorbol 13-acetate (TPA) on mouse skin. | |
| BCN5758 | 4,9-Dihydroxy-alpha-lapachone |
| 1. 4,9-Dihydroxy-alpha-lapachone has antitumor-promoting effects, it exhibits significant inhibitory activity against 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced Epstein-Barr virus early antigen (EBV-EA) activation in Raji cells. 2. 4,9-Dihydroxy-alpha-lapachone exhibits potent inhibitory effects on lipopolysaccharide-induced NO synthesis in RAW 264.7 cells , with IC(50) value of 2.73 microM. | |
| BCN6154 | Hyptadienic acid |
| 1. Hyptadienic acid exhibits moderate cytotoxicity against HepG2 cells. 2. Hyptadienic acid shows a marked anti-inflammatory effect, it also exhibits strong antitumor-promoting activity in an in vivo two-stage carcinogenesis test of mouse tumor by using 7,12-dimethylbenz(a)anthracene (DMBA) as an initiator and TPA as a promoter. | |
| BCN6253 | 21-Episerratenediol |
| 1. 21-Episerratenediol may be as a potent cancer chemopreventive agent. | |
